cnmd: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30
Net income	30,316
Depreciation	13,077
Amortization of deferred debt issuance costs	4,107
Amortization	42,354
Stock-based compensation	23,352
Deferred income taxes	2,711
Non-cash adjustments to fair value of contingent consideration liability	3,504
Loss on early extinguishment of debt	363
Accounts receivable	-20,310
Inventories	15,242
Accounts payable	3,863
Accrued compensation and benefits	8,990
Other assets	12,934
Other liabilities	-417
Net cash provided by operating activities	124,354
Purchases of property, plant and equipment	14,695
Other	-850
Net cash used in investing activities	-13,845
Payments on term loan	79,821
Proceeds from term loan	25,234
Payments on revolving line of credit	508,432
Proceeds from revolving line of credit	508,432
Payments to redeem convertible notes	0
Payments related to contingent consideration	22,577
Payments related to debt issuance costs	2,897
Dividends paid on common stock	18,555
Other, net	166
Net cash used in financing activities	-98,450
Effect of exchange rate changes on cash and cash equivalents	2,411
Net increase in cash and cash equivalents	14,470
Cash and cash equivalents at beginning of period	24,459
Cash and cash equivalents at end of period	38,929

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

cnmd: the cashflow